{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T18:20:42Z","timestamp":1772907642848,"version":"3.50.1"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1R43AI136195-01A1"],"award-info":[{"award-number":["1R43AI136195-01A1"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R43AI136195-01A1"],"award-info":[{"award-number":["1R43AI136195-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,1,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Infection frequently complicates the treatment of combat-related wounds, impairs healing, and leads to worse outcomes. To better manage wound infections, antimicrobial therapies that are effective against biofilm and designed for direct wound application are needed. The primary objective of this work was to evaluate a chitosan matrix for delivery of two engineered antimicrobial peptides, (ASP)-1 and ASP-2, to treat biofilm-associated bacteria. A secondary objective was to determine whether replacing the levorotatory (L) form amino acids in ASP-2 with dextrorotatory (D) form amino acids would impact peptide activity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Materials and Methods<\/jats:title>\n                  <jats:p>Chitosan gels loaded with antimicrobial peptides were evaluated for peptide release over 7\u00a0days and tested for efficacy against biofilms grown both in vitro on polymer mesh and ex vivo on porcine skin.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>When delivered via chitosan, 70% to 80% of peptides were released over 7\u00a0days. Gels eradicated biofilms of gram-positive and gram-negative, drug-resistant bacteria in vitro and ex vivo. Under the conditions tested, no meaningful differences in peptide activity between the L and D forms of ASP-2 were detected.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Chitosan serves as an effective delivery platform for ASP-1 and ASP-2 to treat biofilm-embedded bacteria and warrants further development as a topical treatment.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/milmed\/usz222","type":"journal-article","created":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T20:02:47Z","timestamp":1582142567000},"page":"637-643","source":"Crossref","is-referenced-by-count":19,"title":["Novel Antimicrobial Peptides Formulated in Chitosan Matrices are Effective Against Biofilms of Multidrug-Resistant Wound Pathogens"],"prefix":"10.1093","volume":"185","author":[{"given":"Jennifer A","family":"Neff","sequence":"first","affiliation":[{"name":"Allvivo Vascular, Inc., 20914 Bake Parkway, Suite 100, Lake Forest, CA 92630"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danir F","family":"Bayramov","sequence":"first","affiliation":[{"name":"Allvivo Vascular, Inc., 20914 Bake Parkway, Suite 100, Lake Forest, CA 92630"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esha A","family":"Patel","sequence":"first","affiliation":[{"name":"Allvivo Vascular, Inc., 20914 Bake Parkway, Suite 100, Lake Forest, CA 92630"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Miao","sequence":"first","affiliation":[{"name":"Allvivo Vascular, Inc., 20914 Bake Parkway, Suite 100, Lake Forest, CA 92630"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,2,19]]},"reference":[{"issue":"4 Suppl 2","key":"2020021912093633400_ref1","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1097\/TA.0000000000000768","article-title":"Lessons of war: combat-related injury infections during the Vietnam war and operation Iraqi and enduring freedom","volume":"79","author":"Blyth","year":"2015","journal-title":"J Trauma Acute Care Surg"},{"key":"2020021912093633400_ref2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12879-015-0972-2","article-title":"Clinical infectious outcomes associated with biofilm-related bacterial infections: a retrospective chart review","volume":"15","author":"Barsoumian","year":"2015","journal-title":"BMC Infect Dis"},{"key":"2020021912093633400_ref3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.addr.2016.07.010","article-title":"Beyond conventional antibiotics - new directions for combination products to combat biofilm","volume":"112","author":"Bayramov","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"2020021912093633400_ref4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.molmed.2013.11.005","article-title":"Proteases: common culprits in human skin disorders","volume":"20","author":"de Veer","year":"2014","journal-title":"Trends Mol Med"},{"issue":"8","key":"2020021912093633400_ref5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1089\/wound.2012.0370","article-title":"Proteases and delayed wound healing","volume":"2","author":"McCarty","year":"2013","journal-title":"Adv Wound Care"},{"issue":"1","key":"2020021912093633400_ref6","doi-asserted-by":"crossref","first-page":"13136","DOI":"10.1038\/s41598-017-13197-3","article-title":"Proteolytic signatures define unique thrombin-derived peptides present in human wound fluid in vivo","volume":"7","author":"Saravanan","year":"2017","journal-title":"Sci Rep"},{"issue":"6","key":"2020021912093633400_ref7","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/iwj.12790","article-title":"The detrimental impact of extracellular bacterial proteases on wound healing","volume":"14","author":"Lindsay","year":"2017","journal-title":"Int Wound J"},{"issue":"10","key":"2020021912093633400_ref8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/wound.2015.0673","article-title":"Extracellular bacterial proteases in chronic wounds: a potential therapeutic target?","volume":"5","author":"Suleman","year":"2016","journal-title":"Adv Wound Care"},{"issue":"4","key":"2020021912093633400_ref9","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1021\/acschembio.5b01006","article-title":"A potent d-protein antagonist of VEGF-A is nonimmunogenic, metabolically stable, and longer-circulating in vivo","volume":"11","author":"Uppalapati","year":"2016","journal-title":"ACS Chem Biol"},{"issue":"4","key":"2020021912093633400_ref10","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/iwj.12142","article-title":"Antimicrobial dressing efficacy against mature Pseudomonas aeruginosa biofilm on porcine skin explants","volume":"12","author":"Phillips","year":"2015","journal-title":"Int Wound J"},{"issue":"5","key":"2020021912093633400_ref11","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/wrr.12074","article-title":"Development of a novel ex vivo porcine skin explant model for the assessment of mature bacterial biofilms","volume":"21","author":"Yang","year":"2013","journal-title":"Wound Repair Regen"},{"issue":"7","key":"2020021912093633400_ref12","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1586\/eri.11.59","article-title":"Chitosan preparations for wounds and burns: antimicrobial and wound-healing effects","volume":"9","author":"Dai","year":"2011","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"1","key":"2020021912093633400_ref13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2009.07.019","article-title":"Chitosan-based hydrogels for controlled, localized drug delivery","volume":"62","author":"Bhattarai","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"2020021912093633400_ref14","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3390\/md13031133","article-title":"Chitin and chitosan preparation from marine sources: structure, properties and applications","volume":"13","author":"Younes","year":"2015","journal-title":"Mar Drugs"},{"issue":"suppl_1","key":"2020021912093633400_ref15","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/milmed\/usx150","article-title":"Ciprofloxacin and Rifampin dual antibiotic-loaded biopolymer chitosan sponge for bacterial inhibition","volume":"183","author":"Wells","year":"2018","journal-title":"J Mil Med"},{"issue":"4","key":"2020021912093633400_ref16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/jfb9040056","article-title":"Development and evaluation of an injectable chitosan\/beta-Glycerophosphate paste as a local antibiotic delivery system for trauma care","volume":"9","author":"Boles","year":"2018","journal-title":"J Funct Biomater"},{"issue":"suppl_1","key":"2020021912093633400_ref17","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/milmed\/usx161","article-title":"Local delivery of Amikacin and Vancomycin from chitosan sponges prevent Polymicrobial implant-associated biofilm","volume":"183","author":"Boles","year":"2018","journal-title":"J Mil Med"},{"issue":"4","key":"2020021912093633400_ref18","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/mabi.201500347","article-title":"Polymicrobial biofilm inhibition effects of acetate-buffered chitosan sponge delivery device","volume":"16","author":"Jennings","year":"2016","journal-title":"Macromol Biosci"},{"issue":"9","key":"2020021912093633400_ref19","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/BOT.0b013e3181ed296c","article-title":"Local antibiotic delivery using tailorable chitosan sponges: the future of infection control?","volume":"24","author":"Stinner","year":"2010","journal-title":"J Orthop Trauma"},{"issue":"3","key":"2020021912093633400_ref20","doi-asserted-by":"crossref","first-page":"427","DOI":"10.15171\/apb.2017.051","article-title":"Nanoparticles of chitosan loaded ciprofloxacin: fabrication and antimicrobial activity","volume":"7","author":"Sobhani","year":"2017","journal-title":"Adv Pharm Bull"},{"issue":"3","key":"2020021912093633400_ref21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/wound.2011.0333","article-title":"Clinically addressing biofilm in chronic wounds","volume":"1","author":"Attinger","year":"2012","journal-title":"Adv Wound Care (New Rochelle)"},{"issue":"Suppl 9","key":"2020021912093633400_ref22","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.12968\/jowc.2016.25.Sup9.S11","article-title":"Clinical investigation of biofilm in non-healing wounds by high resolution microscopy techniques","volume":"25","author":"Hurlow","year":"2016","journal-title":"J Wound Care"},{"issue":"6","key":"2020021912093633400_ref23","first-page":"S1","article-title":"Wound biofilm: current perspectives and strategies on biofilm disruption and treatments","volume":"29","author":"Snyder","year":"2017","journal-title":"Wounds"},{"key":"2020021912093633400_ref24","first-page":"107","article-title":"Multidrug tolerance of biofilms and persister cells","volume":"322","author":"Lewis","year":"2008","journal-title":"Curr Top Microbiol Immunol"},{"issue":"7","key":"2020021912093633400_ref25","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1007\/s00253-012-4439-8","article-title":"The novel antimicrobial peptide PXL150 in the local treatment of skin and soft tissue infections","volume":"97","author":"Myhrman","year":"2013","journal-title":"Appl Microbiol Biotechnol"},{"issue":"5","key":"2020021912093633400_ref26","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijantimicag.2009.05.003","article-title":"Antimicrobial and antifungal activities of a novel cationic antimicrobial peptide, omiganan, in experimental skin colonisation models","volume":"34","author":"Rubinchik","year":"2009","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"2020021912093633400_ref27","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/jbcr\/irx041","article-title":"A surfactant-based dressing to treat and prevent Acinetobacter baumannii biofilms","volume":"39","author":"Yang","year":"2018","journal-title":"J Burn Care Res"},{"issue":"2","key":"2020021912093633400_ref28","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.chembiol.2015.01.002","article-title":"D-enantiomeric peptides that eradicate wild-type and multidrug-resistant biofilms and protect against lethal Pseudomonas aeruginosa infections","volume":"22","author":"de la Fuente-Nunez","year":"2015","journal-title":"Chem Biol"},{"key":"2020021912093633400_ref29","doi-asserted-by":"crossref","first-page":"43384","DOI":"10.1038\/srep43384","article-title":"D-form KLKLLLLLKLK-NH2 peptide exerts higher antimicrobial properties than its L-form counterpart via an association with bacterial cell wall components","volume":"7","author":"Manabe","year":"2017","journal-title":"Sci Rep"},{"issue":"11","key":"2020021912093633400_ref30","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1021\/co400072q","article-title":"Short antibacterial peptides with significantly reduced hemolytic activity can be identified by a systematic L-to-D exchange scan of their amino acid residues","volume":"15","author":"Albada","year":"2013","journal-title":"ACS Comb Sci"},{"issue":"Suppl 2","key":"2020021912093633400_ref31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/milmed\/usy077","article-title":"Infection prevention in combat-related injuries","volume":"183","author":"Saeed","year":"2018","journal-title":"J Mil Med"},{"issue":"3 Suppl","key":"2020021912093633400_ref32","doi-asserted-by":"crossref","first-page":"S277","DOI":"10.1097\/TA.0b013e318163c3e4","article-title":"Prevention and management of infections associated with burns in the combat casualty","volume":"64","author":"D\u2019Avignon","year":"2008","journal-title":"J Trauma"},{"issue":"2","key":"2020021912093633400_ref33","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2174\/157489110791233522","article-title":"Topical antimicrobials for burn wound infections","volume":"5","author":"Dai","year":"2010","journal-title":"Recent Pat Antiinfect Drug Discov"},{"key":"2020021912093633400_ref34","first-page":"CD006478","article-title":"Topical silver for preventing wound infection","volume":"3","author":"Storm-Versloot","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 1","key":"2020021912093633400_ref35","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/milmed\/usx135","article-title":"A novel peptide-based antimicrobial wound treatment is effective against biofilms of multi-drug resistant wound pathogens","volume":"183","author":"Bayramov","year":"2018","journal-title":"J Mil Med"},{"issue":"1","key":"2020021912093633400_ref36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.burns.2009.02.017","article-title":"Burns, biofilm and a new appraisal of burn wound sepsis","volume":"36","author":"Kennedy","year":"2010","journal-title":"Burns"},{"issue":"7","key":"2020021912093633400_ref37","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1302\/2046-3758.77.BJR-2018-0043.R1","article-title":"The effect of local antibiotic prophylaxis when treating open limb fractures: a systematic review and meta-analysis","volume":"7","author":"Morgenstern","year":"2018","journal-title":"Bone Joint Res"},{"issue":"8","key":"2020021912093633400_ref38","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1302\/0301-620X.91B8.22216","article-title":"Locally-administered antibiotics in wounds in a limb","volume":"91","author":"Branstetter","year":"2009","journal-title":"J Bone Joint Surg Br"},{"issue":"5","key":"2020021912093633400_ref39","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00264-014-2293-2","article-title":"Systematic review and meta-analysis of the additional benefit of local prophylactic antibiotic therapy for infection rates in open tibia fractures treated with intramedullary nailing","volume":"38","author":"Craig","year":"2014","journal-title":"Int Orthop"},{"issue":"4","key":"2020021912093633400_ref40","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/apm.12673","article-title":"Antibiotic treatment of biofilm infections","volume":"125","author":"Ciofu","year":"2017","journal-title":"APMIS"},{"key":"2020021912093633400_ref41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-09782-4_1","article-title":"Persister cells in biofilm associated infections","volume":"831","author":"Conlon","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"2020021912093633400_ref42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-3-642-28951-4_8","article-title":"Persister cells: Molecular mechanisms related to antibiotic tolerance","volume":"211","author":"Lewis","year":"2012","journal-title":"Handb Exp Pharmacol"},{"issue":"4","key":"2020021912093633400_ref43","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/apm.12687","article-title":"Orthopaedic biofilm infections","volume":"125","author":"Zimmerli","year":"2017","journal-title":"APMI"},{"issue":"12","key":"2020021912093633400_ref44","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.2217\/fmb.15.109","article-title":"Biofilm models of polymicrobial infection","volume":"10","author":"Gabrilska","year":"2015","journal-title":"Future Microbiol"},{"key":"2020021912093633400_ref45","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/1471-2334-14-190","article-title":"Biofilms and persistent wound infections in United States military trauma patients: a case-control analysis","volume":"14","author":"Akers","year":"2014","journal-title":"BMC Infect Dis"}],"container-title":["Military Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/milmed\/article-pdf\/185\/Supplement_1\/637\/32524438\/usz222.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/milmed\/article-pdf\/185\/Supplement_1\/637\/32524438\/usz222.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T20:03:09Z","timestamp":1582142589000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/milmed\/article\/185\/Supplement_1\/637\/5740707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":45,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2020,2,19]]},"published-print":{"date-parts":[[2020,1,7]]}},"URL":"https:\/\/doi.org\/10.1093\/milmed\/usz222","relation":{},"ISSN":["0026-4075","1930-613X"],"issn-type":[{"value":"0026-4075","type":"print"},{"value":"1930-613X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,1]]},"published":{"date-parts":[[2020,1]]}}}